MARKET ACCESS
Being extremely focused on the markets of Central Asia and in particularly on CIS countrys and Africa , we have developed and successfully executed sound tools to evaluate the market potential of any new medicine. Our deep knowledge of the market, stakeholders and the fact that we are one of the leading broker and distributors on the market, allows us to provide market insights and to formulate possible market entrance strategies. This includes the identification of priority therapeutic areas, the analysis of product life cycles, the competitive environment, legislation and more. More than just words, if we identify potential in a proposed medicine, we conclude exclusive distribution contracts with contractual sales obligations. Our approach is more practical and market-oriented than purely theoretical. This way we drive the success of our partners.
The Market of Uzbekistan
Strategically located in the heart of Central Asia, Uzbekistan is the largest country in CA by population, with more than 32 million inhabitants. The rapidly developing and growing economy of the country has recently attracted international attention. As the country opened up for investments, so did its pharmaceuticals market. The healthcare system is undergoing structural changes with private hospitals and medical providers entering the market. The political system is stable and transparent, which makes Uzbekistan a very promising emerging market.
CONTACT: andris@prx-pharmax.com
The Market of Kazakstan
According to Kazakhstan General Economic Activity Classifier 03-2019, production of basic pharmaceutical products and pharmaceutical drugs includes production of basic pharmaceuticals and production of pharmaceuticals and medical goods.
In the last five years, the production of basic pharmaceutical products has grown annually by 26.6%, reaching US$ 449.8 million in 2021. Pharmaceutical drugs dominate in the structure of pharmaceuticals – 97%, while the share of other pharmaceuticals is 3%. Statistics agencies do not keep data on the production of medical goods.
Kazakhstan does not produce raw materials – substances, which complicates further production of pharmaceuticals and makes the country dependent on imports of substances. • Pharma companies are concentrated in Almaty region, Karaganda region, the cities of Shymkent and Almaty distinguished by an extensive logistics and transport infrastructure, easy access to the consumers, raw materials and labor resources.
Pharmaceutical production has immense potential for further development. State support against the backdrop of demand for medicines and the introduction of new standards and laws aiding sector modernisation are key in increasing production capacity growth for Kazakhstan businesses, helping reduce import dependence and increase exports.
Production of medicines and other pharmaceuticals: Shymkent, 38% Almaty Oblast, 24% City of Almaty, 21% Karaganda Oblast, 11% East Kazakhstan, 1% Aktobe Oblast, 1% North Kazakhstan, 1% Pavlodar Oblast, 1% Other, 2% US$ 344 million Production of medicines and other pharmaceuticals Source: Bureau of national statistics of the Agency for strategic planning and reforms of the Republic of Kazakhstan Structure of production by regions, 2020* ** No data available for 2021.
CONTACT: ANDRIS MELNALKSNIS andris@prx-pharmax.com
The Market of Kyrgyzstan
The Pharmacies market in Kyrgyzstan is expected to experience significant growth in the coming years. By 2024, the projected revenue for this market is estimated to reach US$76.01m. This growth is anticipated to continue at an annual rate of 2.17% from 2024 to 2028, resulting in a market volume of US$82.84m by the end of this period. When compared on a global scale, United States is expected to generate the highest revenue in the Pharmacies market, with an estimated amount of US$387.30bn in 2024. This highlights the significant market potential and opportunities available in this industry. In terms of revenue per person, in Kyrgyzstan is projected to generate approximately US$11.11 in 2024.
This indicates the potential economic impact of the Pharmacies market on the country’s population.
In Kyrgyzstan, pharmacies are increasingly focusing on expanding their range of traditional herbal remedies to cater to the demand for natural and alternative medicines.
CONTACT: info@prx-pharmax.com
The Market of Turkmenistan
The Pharmacies market in Turkmenistan is expected to experience significant growth in the coming years. According to projections, the revenue in this market is projected to reach US$701.80m in 2024. This indicates a positive trend for the industry.
Looking ahead, the market is expected to continue growing at an annual growth rate of 8.00% from 2024 to 2028. This steady increase is anticipated to result in a market volume of US$954.90m by 2028. This indicates a promising outlook for the Pharmacies market sector in Turkmenistan. When comparing the revenue generated in Turkmenistan to other countries globally, it is noteworthy that United States is expected to generate the highest revenue in the Pharmacies market.
In 2024, United States is projected to generate a staggering US$387.30bn in revenue. This highlights the significant market potential United States. To put the revenue figures into perspective, it is important to consider the per person revenues.
In Turkmenistan, per person revenues are estimated to be US$106.40 in 2024.
This metric provides insight into the economic impact of the Pharmacies market on the population of Turkmenistan. Overall, the Pharmacies market in Turkmenistan is poised for growth, with significant revenue projections and a positive outlook for the coming years.
The pharmacy market in Turkmenistan is experiencing a surge in demand for traditional herbal remedies. The Pharmacies market in Turkmenistan has been experiencing significant growth in recent years. Customer preferences: Customers in Turkmenistan have shown a strong preference for locally produced pharmaceutical products. This preference is driven by a desire to support domestic industries and the perception that locally produced medications are of higher quality. Additionally, customers in Turkmenistan value personalized service and a wide range of product options when choosing a pharmacy.
Trends in the market: One of the key trends in the Pharmacies market in Turkmenistan is the increasing demand for over-the-counter (OTC) medications. This trend can be attributed to several factors, including the growing awareness and self-medication practices among consumers, as well as the convenience and accessibility of OTC medications. As a result, pharmacies in Turkmenistan are expanding their OTC product offerings to cater to this growing demand. Another trend in the market is the rising popularity of online pharmacies. This trend is driven by the increasing internet penetration in Turkmenistan and the convenience of purchasing medications online. Online pharmacies offer a wide range of products and often provide home delivery services, making it easier for customers to access their medications. This trend is expected to continue as more consumers embrace online shopping.
Local special circumstances: The Pharmacies market in Turkmenistan is influenced by the country’s healthcare system, which provides universal healthcare coverage to its citizens. This means that medications are often subsidized or provided free of charge to patients. As a result, pharmacies in Turkmenistan rely heavily on government reimbursements for their revenue. This reliance on government funding can create challenges for pharmacies, as delays in reimbursements can impact their cash flow.
Underlying macroeconomic factors: The growth of the Pharmacies market in Turkmenistan can also be attributed to the country’s strong economic performance. Turkmenistan has experienced steady economic growth in recent years, driven by its natural gas reserves and government investments in infrastructure projects. This economic growth has resulted in an increase in disposable income and improved living standards, which in turn has led to higher healthcare spending. As a result, consumers in Turkmenistan are able to afford a wider range of medications and healthcare products, driving the growth of the Pharmacies market.
CONTACT: info@prx-pharmax.com
The Market of Ukraine
In Ukraine, the revenue in the Pharmacies market is estimated to reach US$1.77bn in 2024. It is predicted that the revenue will exhibit an annual growth rate (CAGR 2024-2028) of -0.28%, resulting in a market volume of US$1.75bn by 2028. When compared globally, United States is expected to generate the highest revenue of US$387.30bn in 2024. Looking at the per person figures, in Ukraine, each individual is projected to generate revenues of US$46.59 in 2024. In Ukraine, pharmacies are experiencing a surge in demand for over-the-counter medication due to a growing concern for self-medication among the population. The Pharmacies market in Ukraine is experiencing significant growth and development.
Customer preferences: Customers in Ukraine are increasingly seeking convenience and accessibility when it comes to healthcare services. This has led to a growing demand for pharmacies that offer a wide range of products and services, including prescription medications, over-the-counter drugs, and health and wellness products. Customers also value pharmacies that provide personalized advice and guidance on medication usage and health management.
Trends in the market: One of the key trends in the Ukrainian Pharmacies market is the increasing focus on e-commerce and online sales. With the growing penetration of internet and smartphones in the country, more and more customers are turning to online platforms to purchase their medications and healthcare products. This trend is driven by the convenience and ease of online shopping, as well as the availability of a wider range of products compared to traditional brick-and-mortar pharmacies. Another trend in the market is the growing demand for natural and organic healthcare products. Customers in Ukraine are becoming more health-conscious and are seeking products that are free from harmful chemicals and additives. This has led to an increase in the availability and popularity of natural and organic products in pharmacies across the country.
Local special circumstances: The Ukrainian Pharmacies market is also influenced by local special circumstances. The country has a universal healthcare system, which means that a significant portion of prescription medications are subsidized by the government. This has led to a high demand for prescription medications, as they are more affordable for customers. Additionally, the government has implemented regulations to ensure the quality and safety of medications sold in pharmacies, which has further boosted customer confidence in the market.
Underlying macroeconomic factors: Several macroeconomic factors are driving the growth of the Pharmacies market in Ukraine. The country has a large population with increasing disposable incomes, which has led to higher healthcare spending. Additionally, the aging population in Ukraine is contributing to the growth of the market, as older individuals tend to have higher healthcare needs. Furthermore, the government’s focus on improving healthcare infrastructure and services is also supporting the growth of the Pharmacies market. In conclusion, the Pharmacies market in Ukraine is experiencing growth and development due to customer preferences for convenience and accessibility, the increasing focus on e-commerce and online sales, the demand for natural and organic healthcare products, local special circumstances such as the universal healthcare system and government regulations, and underlying macroeconomic factors such as population growth and increasing disposable incomes.
CONTACT: Dekalchuk Petro petro.dekalchuk@prx-pharmax.com
The Market of Afganistan
Healthcare in Afghanistan is slowly improving after it was almost non-existent due to the decades of war. Currently, there are over 3,000 health facilities found throughout Afghanistan. More than 17,000 health posts have been established in the country, including the first neurosurgery hospital. Latest reports say 38,000 Afghan women work as midwives. From 2001 to 2021, Afghanistan experienced improvements in healthcare, with life expectancy increasing from 56 to 64 years and the maternal mortality rate reducing by 50%. 89% of residents living in cities have access to clean water in 2021, up from 16% in 2001. Despite these improvements, Afghanistan’s healthcare system remains poor when compared with its neighboring countries.
Afghanistan became a member of the World Health Organization (WHO) on April 19, 1948. It has an estimated population of around 40 million people. Of this, approximately 35 million are in the country while the remaining 5 million or so reside in Iran, Pakistan and elsewhere around the world. Afghanistan in 2016 had the second lowest health worker density in the Eastern Mediterranean Region (EMR), with a ratio of 4.6 medical doctors, nurses and midwives per 10,000 people, considerably below the threshold for critical shortage of 23 health care professionals per 10,000.
CONTACT: info@prx-pharmax.com